PT-141 + Oxytocin for Men: What Each Component's Research in Men Shows

PT-141 + Oxytocin is a 5 mL vial holding 10 mg PT-141 and 5 mg oxytocin. The prescribing rationale is that PT-141 is aimed at desire and initiation and oxytocin at the orgasmic phase and closeness afterwards. That is a rationale, not a finding. Neither component is a PDE5 inhibitor, neither acts on penile blood flow, and neither raises testosterone.

PT-141 came out of the Melanotan II research line in the 1990s, when male volunteers testing that tanning peptide reported spontaneous erections. Bremelanotide was taken forward for the sexual-function effect.

The detail that matters is "without visual sexual stimulation." An erectile response without stimulation is the signature of a drug acting in the brain rather than on blood flow. A 2005 paper in Urology reported that low-dose intranasal PT-141 with sildenafil produced a larger erectile response than either alone, consistent with the two acting at different points.

The men's programme did not continue to an approved product. The late-phase trials enrolled women only, and the approved label states it is not indicated in men.

• The combination. No study has tested PT-141 and oxytocin together in men, or anyone.
• The compounded dose. Every subcutaneous PT-141 dose in the men's studies was above 1 mg; a combination dose is 0.2 mg PT-141 with 0.1 mg oxytocin.
• The injection route for oxytocin. Every oxytocin study above used a nasal spray measured in IU, which cannot be converted to the milligrams on the vial.
• Desire in men. The PT-141 studies measured erections in a laboratory; the couples study found no oxytocin effect on drive.
• A phase 3 trial in men, for either component's sexual use.
• Long-term safety in men. Most PT-141 safety data come from women, and there are no systematic safety data for oxytocin injection at these doses.

If erection quality is the issue and desire is intact, a PDE5 inhibitor has far larger trials for that job, and a physician may reasonably suggest one first. If the question is desire, PT-141 alone carries the component with the evidence, without an oxytocin component that has no controlled evidence of adding to it. The combination is for a man whose physician judges the orgasm-and-closeness part of the picture worth addressing in the same injection, accepting that the evidence for that part is thin. Using either alongside sildenafil or tadalafil depends on your blood pressure and heart history; raise it at intake rather than combining them yourself.

Almost all published rates come from the PT-141 trials in women at 1.75 mg. The mechanism is the same in men.

There are no systematic safety data for oxytocin at the small subcutaneous doses in this vial. Never take a second dose within 24 hours: the approved bremelanotide label states that consecutive doses within 24 hours have not been shown to add anything and may add to the blood pressure effect. The full picture is in PT-141 side effects.

Bremelanotide is the active ingredient of a product the FDA approved on 21 June 2019 for premenopausal women with acquired, generalised hypoactive sexual desire disorder; that label states it is not indicated in men. Oxytocin is the active ingredient of an approved hospital injection for labour and postpartum bleeding. Both may be compounded by a licensed 503A pharmacy as components of approved products. The combination vial is a different formulation prepared to an individual prescription, has not been reviewed by the FDA, and is not FDA approved.

The combination vial holds 50 doses at 0.10 mL. Because it is used on occasions, the beyond-use date on the label, not the dose count, governs when it is replaced. Every price is all-in, covering medication, physician review, refill management and shipping, with no membership fee. Pepti is cash-pay and does not bill insurance. Vials ship ready to use, refrigerated with ice packs, with sterile syringes and alcohol prep pads. Lot test results are at /quality/lab-results. Your physician sets your directions after reviewing your intake, and they are printed on the vial. Dosing detail is in PT-141 + Oxytocin dosage.

It cannot be bought legitimately without a prescription. Sites selling it "for research use only" are not accountable for identity, purity, sterility or concentration. The prescription route:

1. Complete a free online intake covering your history, medications, blood pressure and heart history, and what has changed about desire, erections or orgasm.
2. A physician licensed in your state reviews it, usually within 24 hours.
3. If it is appropriate, a PCAB-accredited, FDA-registered US 503A compounding pharmacy prepares it to that prescription.
4. It ships refrigerated with your directions printed on the vial.
5. Your physician stays reachable for questions and side effects.

Step by step: how to get PT-141 + Oxytocin prescribed online. Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account.